Phone English: +33 4 57 62 83 79 Français: +33 4 57 62 83 67

GvHD Induction using Immuno-Deficient Mouse Models engrafted with human PBMCs

PBMC from healthy donors are injected in NCG mice – Monitoring of the survival curve and Global clinical score

Exemple using Cyclosporine A treatment in n=12 mice per group (8-week old), 3 PBMCs donors randomised in the study.


  • Cyclosporin-A treatment significantly reduced the mortality and the global clinical score as compared to the vehicle group (PBS)
  • Circulating CD8+ T lymphocytes are decreased by Cyclosporin-A treatment

GVHD Global Clinical Scoring composed of six Scales: 


Immuno Profiling post-GVHD Induction 

Circulating CD8+ T cells are decreased by Cyclosporin A treatment (at D26)



Find out about our Disease Models:

Share this!